(Q42603658)

English

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

scientific article published on 5 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

zoledronic acid

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Brigitte Mlineritsch

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Herbert Stoeger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gero Luschin-Ebengreuth

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Dietmar Heck

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Christian Menzel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Raimund Jakesz

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Michael Seifert

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Michael Hubalek

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gunda Pristauz

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Thomas Bauernhofer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Holger Eidtmann

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Wolfgang Eiermann

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Guenther Steger

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Werner Kwasny

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Peter Dubsky

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gerhard Hochreiner

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ernst-Pius Forsthuber

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Christian Fesl

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Richard Greil

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

5 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

631-641

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641868%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploring the anti-tumour activity of bisphosphonates in early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral bisphosphonate use and breast cancer incidence in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of bisphosphonates and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of clodronate and breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregnancy during gonadotrophin-releasing hormone agonist therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970122-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42603658&oldid=1854797788"